Swiss National Bank
FLNA

Swiss National Bank’s Filana Therapeutics FLNA Stock Holding History

Swiss National Bank’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-89,000
Closed -$210K – 2445
2024
Q4 		$210K Hold
89,000
– – ﹤0.01% 2438
2024
Q3 		$2.62M Buy
89,000
+8,300
+10% +$191K ﹤0.01% 1703
2024
Q2 		$997K Buy
80,700
+2,100
+3% +$44.3K ﹤0.01% 2178
2024
Q1 		$1.59M Hold
78,600
– – ﹤0.01% 1962
2023
Q4 		$1.77M Sell
78,600
-8,600
-10% -$182K ﹤0.01% 1916
2023
Q3 		$1.45M Buy
87,200
+800
+0.9% +$15.9K ﹤0.01% 2033
2023
Q2 		$2.12M Buy
86,400
+800
+0.9% +$19.3K ﹤0.01% 1848
2023
Q1 		$2.06M Sell
85,600
-6,300
-7% -$175K ﹤0.01% 1823
2022
Q4 		$2.71M Buy
91,900
+2,100
+2% +$75.5K ﹤0.01% 1699
2022
Q3 		$3.75M Hold
89,800
– – ﹤0.01% 1450
2022
Q2 		$2.52M Hold
89,800
– – ﹤0.01% 1755
2022
Q1 		$3.33M Buy
89,800
+5,800
+7% +$246K ﹤0.01% 1715
2021
Q4 		$3.67M Hold
84,000
– – ﹤0.01% 1668
2021
Q3 		$5.21M Buy
84,000
+2,300
+3% +$192K ﹤0.01% 1432
2021
Q2 		$6.98M Buy
+81,700
New +$4.38M ﹤0.01% 1255

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Swiss National Bank's FLNA Position: Q1 2025 in Review

Swiss National Bank sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 89,000 shares — an estimated $210K sold.

Swiss National Bank first reported a position in FLNA in Q2 2021 and held it in 15 quarters. The position peaked at $6.98M in Q2 2021. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Swiss National Bank reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Swiss National Bank sold 89,000 Filana Therapeutics shares in Q1 2025, an estimated $210K.
  • Swiss National Bank first reported a position in Filana Therapeutics in Q2 2021 and held it in 15 quarters.
  • Swiss National Bank's Filana Therapeutics position peaked at $6.98M in Q2 2021.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Swiss National Bank's 13F filing for Q1 2025, filed 12 May 2025.